Saturday, January 14, 2006


Hepatitis C Information - MIGENIX Announces Board Changes http://www.migenix.com


MIGENIX Announces Board Changes http://www.migenix.com
T-Net British Columbia - Jan 10 7:01 AM
Vancouver, BC, January 10, 2006--(T-Net)--MIGENIX Inc. announced that Michael Abrams, Ph.D., has retired from its Board. This change reduces the size of the Board to eight directors from nine.Save to My Web

Digene, Third Wave Call Patent Truce
AP via Yahoo! Finance - Jan 13 5:05 AM
Genetic testing product makers Digene Corp. and Third Wave Technologies Inc. said Friday that they agreed to settle a patent feud over human papillomavirus, or HPV, tests.Save to My Web

BLOOD FILES DESTROYED
Sunday Mail - Jan 14 9:39 PM
THOUSANDS of Scots with a killer virus are unaware they are living under a death sentence -and risk infecting many others. They were given blood contaminated with hepatitis C in the 70s and 80s but their identities are unknown because records were destroyed.Save to My Web

'All we want is truth and justice'
BBC News - Jan 14 2:12 AM
One Scottish haemophiliac tells how an injection at the age of six left him with HIV and hepatitis C.Save to My Web

VX-950, Investigational Oral Hepatitis C Protease Inhibitor, Demonstrates Rapid and Dramatic Reduction in Viral Levels
[Press Release] CNW Group via Yahoo! Finance - Jan 09 4:05 AM
New data announced today by Vertex Pharmaceuticals Incorporated show that VX-950, an investigational oral hepatitis C virus protease inhibitor, dosed in combination with pegylated interferon alfa-2a (Pegasys; peg-IFN), achieved a rapid and dramatic reduction in plasma viral RNA levels in patients with chronic genotype 1 HCV infection.Save to My Web